BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND SH2B3, LNK, 10019, ENSG00000111252, Q9UQQ2 AND Prognosis
3 results:

  • 1. Somatic homozygous loss of sh2b3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21.
    Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M
    Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation.
    Mannina D; Gagelmann N; Badbaran A; Ditschkowski M; Bogdanov R; Robin M; Cassinat B; Heuser M; Shahswar R; Thol F; Beelen D; Kröger N
    Eur J Haematol; 2019 Dec; 103(6):552-557. PubMed ID: 31446640
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature.
    Zhou A; Afzal A; Oh ST
    Curr Hematol Malig Rep; 2017 Oct; 12(5):397-405. PubMed ID: 28948488
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.